This Anti-Aging Drug is Disrupting a $600 Billion Industry
Dr. Alan Kaplin, Chief Scientific Officer of MyMD, joins Cheddar Innovates to discuss how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases.
More Videos
Graco Turns 100: How Its Industrial Tech Is Powering the AI Boom
Graco CEO Mark Sheahan explains how the 100-year-old company is expanding into AI infrastructure, data centers and advanced manufacturing.
What Exactly Can Meta’s Muse Do And Where Should We Draw the Line?
Christopher Zara, News Director at Fast Company, explains what Meta’s Muse can actually do and whether its growing access to our lives goes too far.
The CLARITY Act Stalled: What Does It Mean For Crypto Investors?
Ryan Louvar, Chief Policy Officer and Head of Business and Legal Affairs, Digital Assets at WisdomTree, breaks down the CLARITY Act and crypto’s next phase.
The 2026 Gadgets You’ll Want To Know Before 2027
Mark Spoonauer, Global Editor-in-Chief of Tom’s Guide, reveals the year’s biggest tech winners, from Apple’s MacBook Neo to free in-flight Wi-Fi.
Is Your Portfolio All Wrong? Peter Lazaroff On Building The “Perfect” Portfolio
Peter Lazaroff, author of The Perfect Portfolio and host of The Long-Term Investor Podcast, shares how investors can cut through market noise.
Smarter, Not Just Faster: How Embraer Bets on the Future of Flight
Inside Embraer's newest jet, the Praetor 600E: a first-of-its-kind Smart Window, a $7 billion order, and a bet on a new generation of private flyers
